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Background: The apolipoprotein A5 gene (APOA5) -1131 T > C polymorphism is associated with mild
hypertriglyceridemia in type 2 diabetic subjects, and interacts with dietary fat in the determination of triglyceride
concentrations. We examined whether a substitution of whole grains and legumes for refined rice in a high
carbohydrate diet (about 65% of energy derived from carbohydrate) may modify the effect of this variant on
changes in apolipoprotein A-V (apoA-V) and triglyceride concentrations.
Methods: We genotyped the APOA5 -1131 T > C in individuals with impaired fasting glucose (IFG) or newly
diagnosed type 2 diabetes, who were randomly assigned to either a group ingesting whole grain and legume
meals daily or a control group for 12 weeks.
Results: After dietary intervention, we observed significant interactions between the APOA5 -1131 T > C polymorphism
and carbohydrate sources (whole grains and legumes versus refined rice) in the determination of mean percent
changes in triglyceride and apoA-V (P interactions <0.001 and =0.038, respectively). In the refined rice group (n = 93),
the carriers of the risk C allele (n = 50) showed a greater increase in the mean percent changes of triglyceride and
apoA-V than noncarriers after adjusting for HOMA-IR (P = 0.004 and 0.021, respectively). The whole grain and legume
group (n = 92), however, showed a decrease in fasting glucose, HOMA-IR, and triglyceride, and an increase in apoA-V,
irrespective of genotype.
Conclusions: The data showed that the magnitude of the genetic effect of the APOA5 -1131C variant on triglyceride
and apoA-V levels was modulated when substituting consumption of whole grains and legumes for refined rice as a
carbohydrate source in IFG or diabetic subjects.
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The role of apolipoprotein A-V (apoA-V) in the regulation
of triglyceride metabolism has been demonstrated exten-
sively in genetically modified animal models [1] and in a
larger numbers of association studies [2-4]. In association
studies, the most frequently analyzed variant is -1131 T >
C; the C allele has been consistently associated with higher
triglyceride levels. A recent Mendelian randomization
experiment with the APOA5 functional variant -1131 T >C
has suggested a causal relationship between increased
plasma triglyceride concentration and coronary artery
disease (CAD) [5]. In support of this observation,
APOA5 -1131 T > C polymorphism has been associated
with increased risk for CAD, particularly in Koreans for
whom the minor allele frequency is 0.29 [2], which is
much greater than the frequency reported for Caucasians
(0.06) [6,7].
According to the 2010 Korean National Health and
Nutrition Examination Survey (KNHANES V-1),
carbohydrate-derived calories account for 65% of
total caloric intake, and refined rice is the primary
source of carbohydrates in middle-aged adults. This
high carbohydrate intake and high prevalence of the
APOA5 -1131C allele may contribute to the relatively
high mean serum triglyceride concentration (142 mg/dL)
in the Korean population (KNHANES V-1). Although
observational studies and intervention trials have
shown that APOA5 -1131 T > C polymorphism inter-
acts with dietary factors (especially dietary fat) in the
determination of triglyceride concentrations [8-12],
the information on the relationship between the
APOA5 -1131 T > C and triglyceride induced by a
high carbohydrate diet with different carbohydrate
sources is scarce. Lin et al. have recently found
elevated triglyceride levels induced by a high carbo-
hydrate diet in healthy individuals with the APOA5 -
1131C allele [13]. Due to a clear association between
diabetic dyslipidemia and APOA5 -1131 T > C poly-
morphism [14] and reducing effects of a high legume
low glycemic index diet on fasting triglyceride in
insulin-resistant subjects [15], it was hypothesized
that the substitution of whole grains and legumes
for refined rice in a high carbohydrate diet could
attenuate or mask the adverse effects of high carbo-
hydrate intake in individuals with the C allele on the
APOA5 -1131 T > C polymorphism. The study focused
specifically on the effects of the APOA5 -1131 T > C
polymorphism on a 12-week randomized, high car-
bohydrate diet intervention with different carbo-
hydrate sources (whole grains and legumes versus
refined rice), and targeted circulating levels of
apoA-V and triglyceride in individuals with impaired
fasting glucose (IFG) or newly diagnosed type 2
diabetes.Methods
Study design and subjects
This is a randomized, open label, controlled, interven-
tion trial to evaluate the efficacy of whole grains and
legumes compared with refined rice on the genetic effect
of the APOA5 -1131C variant on changes in triglyceride
and apolipoprotein A-V concentrations in patients
with impaired fasting glucose or newly diagnosed type
2 diabetes.
Study subjects were selected from participants in a
nutrition genomic study conducted by the National
Leading Research Laboratory of Clinical Nutrigenetics/
Nutrigenomics at Yonsei University. Study subjects were
recruited from the Health Service Center (HSC) during
a routine check-up at National Health Insurance Cor-
poration Ilsan Hospital, Goyang, Korea (during the
period January 2012 to October 2012). Based on the data
screened from the HSC, subjects who were in IFG,
(100 ≤ fasting glucose <126 mg/dL) and newly diagnosed
type 2 diabetes (fasting glucose ≥126 mg/dL) were re-
ferred to the Department of Family Medicine or Internal
Medicine. They were rechecked for their health and lipid
profiles and those who satisfied the study criteria were
recommended to participate in the dietary intervention
program. Finally, those who consented to the program
were included in this study. Exclusion criteria included:
(1) current and/or past history of cardiovascular disease
including angina; (2) liver or kidney dysfunction; (3) thy-
roid or pituitary disease; (4) unstable weight loss/gain
(≥2 kg) over the previous six months; and (5) pregnancy
or lactation. Subjects who were taking medication were
also excluded. A total of 200 Koreans were enrolled; 15
participants subsequently discontinued the study for per-
sonal reasons, and 185 subjects (male: n = 39 and female:
n = 146) completed the study. All subjects provided writ-
ten informed consent before participation in this study,
which was approved by the Institutional Review Board
of Yonsei University.
Dietary intervention and assessment of dietary intake/
physical activity level
One week before starting the 12-week intervention, the
enrolled subjects were asked to visit the center. The sub-
jects’ usual diet information was obtained using both a
24-hour recall method and a semi-quantitative food fre-
quency questionnaire (SQFFQ), of which the validity
had been previously tested [16]. We used the former to
carry out analyses and the latter to check if the data col-
lected by 24-hour recall methods was representative of
the usual dietary pattern. All the subjects were given
written and verbal instructions by a registered dietitian
on completion of a three-day (two weekdays and one
weekend) dietary record every four weeks. Subjects were
instructed to record on the sheet the amount of foods
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weighing the foods. All the participants were advised to
continue their usual diet for one week and instructed to
complete a three-day dietary record as the baseline
measurement, which were then compared with the re-
cords obtained by 24-hour recall methods used on their
previous visit in order to check their records.
After one week, the dietary intervention program
started. Individualized and nutritionally balanced diets
were planned for each subject based on their reported
intakes and Korean Recommended Dietary Allowance
(Korean RDA, Korean Nutrition Society, Seoul, Korea).
The intervention program consisted of the replacing of re-
fined rice intake with one third legumes, one third barleys,
and one third whole grains three times per day as a high
carbohydrate source, and increased vegetable intake to at
least six units (30 to 70 g/unit) per day for sufficient diet-
ary fiber intake. Participants were also instructed to record
their physical activity diary for 24 hours every four weeks.
To check participants’ compliance during the entire
study period, the dietitian conducted bi-weekly interviews
by telephone. Participants were interviewed to discern
whether they were following the program well, including
dietary intake and physical activity. During the study
period, all participants were also encouraged to maintain
their usual lifestyle except for the instructed diet change.
Dietary energy values and nutrient content from the
three-day food records were calculated using the Com-
puter Aided Nutritional analysis program (CAN-pro 2.0,
Korean Nutrition Society, Seoul, Korea). Total energy
expenditure (kcal/day) was calculated from activity pat-
terns including basal metabolic rate, physical activity for
24 hours [17], and specific dynamic action of food. Basal
metabolic rate for each subject was calculated with the
Harris–Benedict equation [18].
Genotyping of APOA5 -1131 T > C
Among the studied five common APOA5 SNPs
(−1131 T > C, −3A > G, 56C > G, 1259 T > C and IVS3 +
476G > A) in several populations [4,10,19], the −1131
T > C and the 56C > G (S19W) are considered to be
functional tag SNPs [3,6,20]. However, the minor allele
19 W was found to be rare in Asian population (0.1 to
3%) [19,21-23]. Thus, only APOA5 -1131 T > C SNP was
selected as a functional SNP to investigate further. Gen-
omic DNA was extracted from 5 mL of whole blood using
a commercially available DNA isolation kit (WIZARD
Genomic DNA purification kit, Promega Corp., Madison,
WI, USA) according to the manufacturer’s protocol.
Genotyping was performed by SNP-IT™ assays using
single primer extension technology (SNPstream 25K™
System, Orchid BioSciences, NJ, United States). The
colorimetric reactions were detected by an enzyme-
linked immunosorbent assay (ELISA) reader, and thegenotype was determined with QCReview™ software
(Orchid Biosciences, Princeton, NJ, United States).
Detailed methods of the clinical laboratory tests have
been previously described [24].
Anthropometric parameters and blood collection
Body weight and height were measured unclothed and
without shoes in the morning. Body mass index (BMI)
was calculated as body weight in kilograms divided by
height in square meters (kg/m2). Waist circumference
was measured at the umbilical level with the subjects
standing after normal expiration, and the hip girth was
measured at the widest part of the hip. The waist and
hip ratio (WHR) was then calculated. Blood pressure
(BP) was obtained from the left arm of seated patients
with an automatic blood pressure monitor (TM- 2654,
A&D, Tokyo, Japan) after 20 minutes of rest. After an
overnight fast, venous blood specimens were collected in
EDTA-(Ethylenediaminetetraacetic acid)-treated or plain
tubes, and centrifuged into plasma or serum, then stored
at −70°C until analysis.
Serum lipid profile and free fatty acids
Fasting total-cholesterol and triglyceride levels were
measured using commercially available kits on a Hitachi
7150 Autoanalyzer (Hitachi Ltd., Tokyo, Japan). After
precipitation of apoB-(apolipoprotein B)-containing
lipoproteins with dextran sulfate magnesium, HDL-
(high-density lipoprotein)-cholesterol concentrations
in the supernatants were enzymatically measured.
LDL-(low-density lipoprotein)-cholesterol was esti-
mated indirectly for subjects with serum triglyceride
levels <400 mg/dL using the Friedwald formula: LDL −
cholesterol = Total − cholesterol–(HDL − cholesterol +
[Triglycerides/5]). LDL-cholesterol for subjects with
serum triglyceride levels ≥400 mg/dL was measured
indirectly.
Fasting glucose, insulin concentration, and homeostasis
model assessment-insulin resistance
Fasting glucose levels were measured by the glucose oxi-
dase method with a Beckman Glucose Analyzer (Beckman
Instruments, Irvine, CA, United States). Insulin levels
were measured by radioimmunoassay using commercial
kits from Immuno Nucleo Corporation (Stillwater, MN,
United States). Insulin resistance (IR) was calculated by
the homeostasis model assessment (HOMA) using the fol-
lowing equation: HOMA − IR = [fasting insulin(μIU/mL) ×
fasting glucose (mmol/L)]/22.5.
Plasma apolipoprotein A-V and serum high sensitivity C
reactive protein
Plasma concentration of apolipoprotein A-V (apoA-V)
was measured using an enzyme immunoassay (Human
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States). The resultant color reaction was read at 450 nm
using a Victor2 (Perkin Elmer life sciences, Turka,
Finland). Serum high sensitivity C-reactive protein (hs-
CRP) levels were measured with an Express Plus™ auto-
analyzer (Chiron Diagnostics Co., Walpole, MA, United
States) using a commercially available, high-sensitivity
CRP-Latex(II) X2 kit (Seiken Laboratories Ltd., Tokyo,
Japan).
Statistical analysis
We used the SPSS version 12.0 programs for Windows
(SPSS Inc., Chicago, IL, United States). Hardy–Weinberg
equilibrium (HWE) analysis for APOA5 -1131 T > C was
performed by Haploview version 3.32. A paired t-test
was used to evaluate the effects of the dietary interven-
tion. One-way analysis of variance (ANOVA) with the
Bonferroni correction or independent t-test was used to
test the genotype effect. Pearson and partial correlation
coefficients were used to determine the relationship
between changes in apoA-V levels and other metabolic
variables. General linear model (GLM) analysis was
also used for the comparison with adjustment forTable 1 Baseline characteristic of the study participants by AP
A
TT (n = 84)




Diet groups [n (%)]
Refined rice 43 (46.2)
Whole grains and legumes 41 (44.6)
Body mass index (kg/m2) 25.5 ± 0.35
Waist hip ratio 0.90 ± 0.01
Systolic BP (mmHg) 119.1 ± 1.70
Diastolic BP (mmHg) 77.1 ± 1.21
Total-cholesterol (mg/dL)∮ 199.7 ± 3.26
LDL-cholesterol (mg/dL)∮ 118.3 ± 3.19
hs-CRP (mg/dL)∮ 0.70 ± 0.09
Glucose (mg/dL)∮ 106.9 ± 1.72
Insulin (uIU/mL)∮ 9.75 ± 0.57
HOMA-IR∮ 2.56 ± 0.17
Free fatty acid (uEq/L)∮ 556.0 ± 22.8
Triglyceride (mg/dL)∮ 138.4 ± 6.81
HDL-cholesterol (mg/dL)∮ 53.7 ± 1.40
Apolipoprotein A-V (ng/mL)∮ 233.7 ± 7.53
Means ± S.E.
∮tested by logarithmic transformation, P-values derived from ANOVA with the Bonfe
male; HDL, high-density lipoprotein; HOMA-IR, Homeostatic model assessment; hs-Cconfounding factors. The interaction between the
−1131 T > C polymorphism and the compliance of the
dietary intervention were tested in the multivariate
interaction test in a regression model after controlling
for potential confounders, including change in the
HOMA-IR. Each variable was examined for normal
distribution and skewed variables were tested after
logarithmic transformation. For descriptive purposes,
mean values of untransformed and unadjusted vari-




Baseline characteristics of participants according to the
APOA5 -1131 T > C genotype are shown in Table 1. The
genotype frequencies did not deviate significantly from
the Hardy-Weinberg equilibrium. The C allele frequency
in subjects with IFG or new-onset type 2 diabetes was
0.314, which is slightly greater than the frequency previ-
ously reported in the healthy Korean population (0.285)
[2]. Genotype frequencies were similar between men and
women, and across diet groups. The APOA5 -1131 T > COA5 -1131 T > C genotype
POA5 -1131 T > C P-value
TC (n = 85) CC (n = 16)
50.1 ± 1.17 50.5 ± 1.97 0.966
0.971
67 (45.9) 13 (8.9)
18 (46.2) 3 (7.7)
0.973
42 (45.2) 8 (8.6)
43 (46.7) 8 (8.7)
25.6 ± 0.28 24.8 ± 0.46 0.604
0.89 ± 0.01 0.88 ± 0.01 0.466
122.4 ± 1.67 114.9 ± 2.90 0.135
77.4 ± 0.99 75.1 ± 2.22 0.716
98.8 ± 3.89 191.4 ± 8.59 0.583
113.9 ± 3.50 110.8 ± 8.39 0.457
0.94 ± 0.15 0.62 ± 0.20 0.157
109.5 ± 2.04 105.4 ± 4.44 0.570
9.54 ± 0.56 9.23 ± 0.82 0.978
2.52 ± 0.16 2.36 ± 0.23 0.998
547.6 ± 20.9 514.9 ± 41.3 0.890
180.5 ± 8.87 170.0 ± 15.3 <0.001
48.7 ± 1.23 46.6 ± 3.27 0.013
199.7 ± 7.47 153.6 ± 12.1 <0.001
rroni method. ANOVA, Analysis of variance; BP, blood pressure; F, female; M,
RP, high-sensitivity C-reactive protein; LDL, low-density lipoprotein.
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ceride (P < 0.001) and HDL-cholesterol (P = 0.013).
Subjects with the C allele showed significantly higher
triglyceride and lower HDL-cholesterol than those
with the TT allele. There was a significant association
between apoA-V levels and the -1131 T > C genotype
(P < 0.001). Subjects with the TC and CC alleles were
found to have values approximately 15% and 34%
lower than those with TT, respectively. Other vari-
ables such as age, BMI, smoking and alcohol con-
sumption, WHR, blood pressure, serum levels of total
cholesterol, LDL-cholesterol, hs-CRP, glucose, insulin,
free fatty acid, and HOMA-IR index were not associ-
ated with genotype at baseline (all P > 0.05). In order
to increase statistical power for the test, we pooled
carriers of the less common allele (TC + CC).
Effects of the 12-week dietary intervention
At baseline and at 12 weeks, we did not find any signifi-
cant difference in age, BMI, WHR, blood pressure, total
cholesterol, LDL-cholesterol, and hs-CRP across the
APOA5 -1131 T > C genotype in both interventionTable 2 Biochemical analysis data and estimates of daily nutr
genotype at baseline and 12 weeks
Whole grains and legumes (n = 92)
TT (n = 41) C allele (n =
Baseline 12 weeks Baseline 12
Glucose (mg/dL)∮ 107.9 ± 2.67 97.9 ± 2.12*** 107.7 ± 2.83 100.
Insulin (uIU/mL)∮ 9.96 ± 0.86 8.69 ± 0.65† 9.49 ± 0.75 8.5
HOMA-IR∮ 2.61 ± 0.25 2.06 ± 0.16** 2.46 ± 0.22 2.0
Free fatty acid (uEq/L)∮ 564.1 ± 34.8 567.0 ± 29.5 548.9 ± 28.5 583
Triglyceride (mg/dL)∮ 139.8 ± 7.56 123.6 ± 6.85*** 186.7 ± 11.4a 173.
HDL-cholesterol (mg/dL)∮ 52.3 ± 1.70 54.9 ± 1.94† 48.6 ± 1.37 51
ApoA-V (ng/dL)∮ 225.8 ± 10.2 249.6 ± 14.0† 190.0 ± 9.03a 215
Total energy
expenditure (kcal/d)
2050.8 ± 43.4 2046.2 ± 42.3 2047.2 ± 49.2 203
Estimates of daily
nutrient intakes
Energy intake (kcal/d) 2261.8 ± 47.0 2266.0 ± 45.3 2205.2 ± 52.4 218
Carbohydrate (%) 64.9 ± 0.93 58.9 ± 0.61*** 65.4 ± 0.44 60.2
Protein (%) 17.1 ± 0.41 20.1 ± 0.25*** 17.4 ± 0.29 20.4
Fat (%) 21.7 ± 0.59 24.7 ± 0.58*** 21.6 ± 0.49 24.3
Crude fiber (g)∮ 8.86 ± 0.46 11.9 ± 0.58*** 10.7 ± 0.64 13.4
PUFA/SFA∮ 1.59 ± 0.14 1.82 ± 0.12* 1.65 ± 0.13 1.8
Means ± S.E. HDL, high-density lipoprotein; HOMA-IR, Homeostatic model assessmen
∮tested by logarithmic transformation.
aP < 0.05 comparison between TT and C allele at whole grains and legumes at base
bP < 0.05 comparison between TT and C allele at whole grain treatment at 12 week
cP < 0.05 comparison between TT and C allele at refined rice at baseline.
dP < 0.05 comparison between TT and C allele at refined rice at 12 week follow-up.
eP < 0.05 comparison between TT at whole grain and refined rice at 12 week follow
fP < 0.05 comparison between C allele at whole grain and refined rice at 12 week fo
†P < 0.1, *P < 0.05, **P < 0.01, ***P < 0.001 compared with the level at baseline in each(whole grains and legumes) and control (refined rice)
groups (data not shown). Means (±SEs) of fasting
glucose, insulin, HOMA-IR index, free fatty acid, tri-
glyceride, HDL-cholesterol, and apoA-V across the
APOA5 -1131 T > C genotype by the dietary interven-
tion and control groups at baseline and 12 weeks are
shown in Table 2. The 12-week dietary intervention
with whole grains and legumes significantly decreased
serum levels of glucose, triglyceride, and HOMA-IR
index irrespective of genotype, although the post-
treatment fasting serum triglyceride level was signifi-
cantly higher in C allele carriers when compared with
TT allele carriers (P = 0.013) (Table 2). In the whole
grain and legume group, C allele carriers showed a
significant decrease in insulin (P = 0.008) and a sig-
nificant increase in HDL-cholesterol (P = 0.020) and
apoA-V (P = 0.005) concentrations; TT allele carriers
showed a marginal decrease in insulin (P = 0.074) and
a marginal increase in HDL-cholesterol (P = 0.067) and
apoA-V (P = 0.088). In the refined rice group, C allele
carriers showed an increase in triglyceride (P < 0.001) and
apoA-V (P = 0.001) concentrations.ient intake according to diets and APOA5 -1131 T > C
Refined rice (n = 93)
51) TT (n = 43) C allele (n = 50)
weeks Baseline 12 weeks Baseline 12 weeks
4 ± 2.54*** 105.9 ± 2.21 108.8 ± 2.51†,e 110.1 ± 2.39 111.5 ± 2.59f
4 ± 0.76** 9.54 ± 0.76 9.65 ± 0.76 9.49 ± 0.62 10.0 ± 0.77
8 ± 0.21** 2.51 ± 0.23 2.60 ± 0.24 2.52 ± 0.18 2.72 ± 0.25f
.8 ± 29.9 548.0 ± 30.0 549.8 ± 37.3 535.6 ± 24.4 558.7 ± 31.5
3 ± 16.8**,b 137.1 ± 11.3 136.3 ± 11.5 170.9 ± 10.7c 218.1 ± 21.7***,d,f
.2 ± 1.51* 55.1 ± 2.21 55.9 ± 1.98 48.2 ± 1.88c 49.3 ± 1.93d
.7 ± 9.70** 241.2 ± 11.1 239.5 ± 12.7 194.9 ± 10.2c 223.9 ± 9.92**
7.8 ± 45.6 2018.5 ± 44.9 2009.7 ± 41.5 2066.4 ± 36.7 2055.0 ± 34.8
9.4 ± 45.1 2128.6 ± 45.3 2120.3 ± 43.0 2213.5 ± 39.9 2204.6 ± 38.6
± 0.59*** 65.8 ± 0.82 65.0 ± 0.46e 64.6 ± 1.02 64.0 ± 0.56f
± 0.25*** 7.4 ± 0.22 17.3 ± 0.20e 17.2 ± 0.37 16.7 ± 0.31f
± 0.55*** 21.2 ± 0.43 21.8 ± 0.50e 21.4 ± 0.61 21.2 ± 0.46 f
± 0.79*** 10.4 ± 0.65 10.6 ± 0.70 10.3 ± 0.71 10.0 ± 0.52f
5 ± 0.11* 1.76 ± 0.15 1.73 ± 0.15 1.65 ± 0.14 1.49 ± 0.13f





group by paired t-test.
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across the APOA5 -1131 T > C genotype by the dietary
intervention and control groups at baseline and 12 weeks
are shown in Table 2. In the whole grain and legume
group, there were significant increases from the baseline
in fiber, percent energy intake from fat and protein,
and the polyunsaturated fatty acids-to-saturated fatty
acids ratio.
Interaction between APOA5 -1131 T > C genotype and
diet on 12-week changes in apoA-V and triglyceride
There was no significant gene-diet interaction on serum
insulin, free fatty acid, and HDL-cholesterol (data not
shown). The genotype effects of APOA5 -1131 T > C on
mean (±SEs) percent changes in apoA-V and triglyceride
by dietary intervention and control groups at 12 weeks
are shown in Figure 1. At 12 weeks, after adjustment for
age, sex, BMI, smoking and drinking, the results showed
a significant interaction between the APOA5 -1131 T > C
genotype and dietary carbohydrate source (whole grains
and legumes compared with refined rice) on mean percent
changes in apoA-V (P-interaction = 0.038) and triglyceride
(P-interaction < 0.001). In the refined rice group, subjects
with the risk C allele had a greater increase in apoA-V
concentration than did those with the TT allele, both
before (P = 0.012) and after adjusting for the HOMA-IR








Whole grain Refined rice
P=0.237 P=0.021
P for interaction = 0.038
Figure 1 Genotype effect of APOA5 -1131 T > C on mean percent cha
grains and legumes and refined rice groups at 12 weeks. Means ± SE.
in HOMA-IR. HOMA-IR, homeostatic model assessment; TG, triglyceride.related to changes in apoA-V in the whole grain and
legume group. With respect to the triglyceride change, in
the refined rice group subjects with the risk C allele had a
greater increase in triglyceride concentration than did
those with the TT allele, both before (P = 0.017) and after
adjusting for the HOMA-IR index (P = 0.004), however
the genetic variant was not related to changes in triglycer-
ide in the whole grain and legume group.
Relationship between changes in plasma apoA-V levels
and metabolic parameter
Correlations between changes in apoA-V levels and
metabolic parameters (baseline and changed levels of
apoA-V, free fatty acids, triglyceride, and HDL-
cholesterol) were determined after adjusting for age,
sex, and BMI changes. Overall, changes in apoA-V
levels were negatively correlated with baseline apoA-V
(r= −0.345, P < 0.001), free fatty acid (r = −0.188, P = 0.016),
and HDL-cholesterol (r =−0.178, P = 0.016), and positively
correlated with changes in free fatty acid (r = 0.163,
P = 0.037) and triglyceride (r = 0.218, P = 0.003). In
subjects with the TT allele (n = 84), changes in apoA-V
levels were negatively correlated with baseline apoA-V
(r = −0.223, P = 0.046), free fatty acid (r = −0.250, P =
0.029), HDL-cholesterol (r = −0.220, P = 0.049), and
changes in triglyceride (r = −0.324, P = 0.003) and posi-









Whole grain Refined rice
P=0.534 P=0.004
P for interaction < 0.001
nges in fasting apolipoprotein A-V and triglyceride by whole
P-values derived from an independent t-test after adjusting for change
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changes in apoA-V levels were negatively correlated with
baseline apoA-V (r = −0.408, P < 0.001) and positively cor-
related with changes in free fatty acid (r = 0.245, P = 0.025)
and triglyceride (r = 0.458, P < 0.001).
In this 12-week randomized, high carbohydrate diet
intervention trial (approximately 65% of energy derived
from carbohydrates) with different carbohydrate sources
(whole grains and legumes versus refined rice), we ob-
served a significant interaction between the APOA5
-1131 T > C polymorphism and carbohydrate sources in
relation to mean percent changes in triglyceride and
apoA-V concentrations. Compared to subjects with the
TT allele, individuals with the risk C allele exhibited a
greater increase in triglyceride and apoA-V responses to
a control (refined-rice) diet, but had no genotype effect
when assigned an intervention (whole grain and legume)
diet. In previous observations, ingestion of soy protein
was associated with a decrease of 10.5% in triglyceride
levels [25], and replacing refined rice with legumes and
increasing vegetable intake showed a 15% reduction in
triglyceride levels [26]. Thus, it is acceptable that in this
study, dietary intervention shows a 10% decrease in
triglyceride levels in TT allele participants, while a 20%
increase in C allele carriers would result from a genetic
difference that exhibits higher triglyceride concentra-
tions. These findings suggest that different carbohydrate
sources in a high carbohydrate diet may modulate the
genetic effect of the APOA5 -1131C variant on changes
in triglyceride and apoA-V concentrations.
Despite no significant difference in baseline triglycer-
ide values between the individuals carrying the -1131C
variant of APOA5 gene in control and intervention
groups, undergoing refined rice consumption had a
higher value of triglyceride at 12 weeks. The increase in
triglyceride in control subjects with the C allele is in
agreement with the previous study that APOA5 -1131C-
allele carriers had higher triglyceride concentrations in
response to a high-carbohydrate and low-fat diet (70 and
15% of energy derived from carbohydrate and fat,
respectively) in young, healthy, Chinese adults [13].
However, the reduction of triglyceride concentrations by
a 9-week low-calorie and low-fat (52 and 30% of energy
derived from carbohydrate and fat, respectively) inter-
vention was not associated with the APOA5 -1131 T > C
in overweight and obese nondiabetic Czech females [27].
These contradictory results might be partly explained by
differences in calorie percent from carbohydrate (70%
versus. 52%) or ethnicity (Asians versus Caucasians).
Whole grain and legume consumption is known to
decrease insulin resistance or insulin demand and im-
prove lipid profiles, including decreased triglyceride [28].
In particular, soy intake was shown to be associated with
increased HDL-cholesterol and decreased triglyceride[29]. This is in agreement with our finding that -1131C
carriers taking whole grains and legumes showed a
significant decrease in fasting triglyceride at 12 weeks in
contrast with an increase in C-allele subjects consuming
refined rice. This observation of the present study could
demonstrate that the magnitude of the effect of APOA5
gene on triglyceride levels is attenuated or masked when
conditions are metabolically improving, such as a de-
crease in glucose, insulin, and HOMA-IR index and an
increase in HDL-cholesterol and apoA-V as a conse-
quence of the replacement of refined rice with whole
grain and legume. This result is consistent with the pre-
vious reports that lifestyle modification has attenuated
the biological effect of genetic predisposition on meta-
bolic profile and diabetes risk [30].
Similarly to previous observations [2,31,32], the pres-
ence of the -1131C allele was linked to lower plasma
apoA-V concentrations at baseline in both control and
intervention groups. After 12 weeks, however, −1131C
allele carriers showed a significant increase in apoA-V
concentrations, and the apoA-V levels of C allele carriers
were no longer significantly different from those of TT
allele carriers. This result contrasts the previous sugges-
tion that increased triglyceride levels in individuals with
the APOA5 -1131C allele after consumption of a high-
carbohydrate and low-fat diet might possibly result from
reducing the translational efficiency of apoA-V in the
-1131C allele [13]. This contrasting result could be
partly due to increased apoA-V production resulting
from high triglyceride induced by a high carbohydrate
diet with refined rice. An increase in triglyceride could pro-
vide a potential explanation as to why apoA-V production
in the liver is increased as a regulatory mechanism to cover
the increased need of lipolysis [33]. This explanation might
be supported by the earlier observations of a direct correl-
ation of apoA-V levels to serum triglyceride in hypertri-
glyceridemia [34,35] and type 2 diabetes [14,36].
Although a correlation between changes in apoA-V
and triglyceride was positive in -1131C allele carriers but
negative in TT allele carriers, a direct correlation be-
tween changes in apoA-V and fasting free fatty acid was
observed in overall subjects. Similarly, Hahne et al. also
found an independent direct association between plasma
apoA-V and free fatty acid levels in humans [37]. Due to
the higher triglyceride levels in C allele carriers than TT
allele carriers at baseline, it is speculated that the oppos-
ite associations between apoA-V and triglyceride accord-
ing to genotype might likely be caused by the apoA-V
effects on the baseline triglyceride. This observation is in
line with Hyun et al. [24] who suggested that the nega-
tive correlation of apoA-V with triglyceride was reversed
by fasting serum triglyceride partly due to the insuffi-
cient lipoprotein lipase-stimulatory activity of apoA-V in
hypertriglyceridemia.
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http://www.trialsjournal.com/content/15/1/100Several limitations of the study also warrant consider-
ation. Firstly, dietary intake information was based on
self-reports obtained from weighed food. However,
measurement errors from self-reported dietary intake
and lifestyle variables have been shown to be relatively
small [38]. Secondly, because of the small sample size,
the results of genetic analyses should be interpreted with
caution. Finally, the euglycemic glucose clamp technique
and 2-hour glucose tolerance were not performed. Des-
pite these limitations, the results of this study indicate
that IFG or diabetic subjects with the APOA5 -1131C
variant could be more susceptible than those with
APOA5 -1131TT homozygotes to the adverse effects of
a high carbohydrate diet with refined rice and be more
prone to having an elevation of triglyceride even with an
increase in apoA-V concentration. Conversely, the mag-
nitude of the effect of APOA5 gene on triglyceride levels
was attenuated or masked when conditions were meta-
bolically improving in substituted consumption of whole
grains and legumes for refined rice as a carbohydrate
source.
Conclusions
In IFG or diabetic individuals found to carry the APOA5
-1131C variant, therefore, the replacement of refined rice
with whole grains and legumes in a high carbohydrate
diet may need to be considered to prevent diabetic
hypertriglyceridemia.
Abbreviations
APOA5: Apolipoprotein A5 gene; apoA-V: Apolipoprotein A-V;
apoB: apolipoprotein B; BMI: Body mass index; BP: Blood pressure, CAD,
Coronary artery disease; EDTA: Ethylenediaminetetraacetic acid; HDL:
high-denstiy lipoprotein; HOMA: Homeostasis model assessment; hs-
CRP: High sensitivity C reactive protein; IFG: Impaired fasting glucose;
IR: Insulin resistance; LDL: low-density lipoprotein; PUFA: Polyunsaturated
fatty acid; SFA: Saturated fatty acid; SNP: Single-nucleotide polymorphism;
WHR: Waist and hip ratio.
Competing interests
All authors declare that they have no competing interests.
Authors’ contributions
RK, MK, JSC, S–HL, and JHL analyzed data, developed the study protocol
and design, and read, commented on, and contributed to the submitted
manuscript. JHL provided then research funding, developed the study
protocol and design, and wrote the manuscript. JHL is the guarantor of this
work and, as such, had full access to all the data in the study and takes
responsibility for the integrity of the data and the accuracy of the data
analysis. All authors read and approved the final manuscript.
Acknowledgments
This research was supported by the National Research Foundation of
Korea (NRF) and funded by the Ministry of Science, ICT & Future Planning
(2006–2005306, 2010–0015017, and 2012M3A9C4048762).
Author details
1Department of Food and Nutrition, College of Human Ecology, National
Leading Research Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei
University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Korea. 2Department
of Food and Nutrition, Brain Korea 21 PLUS Project, College of Human
Ecology, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749,Korea. 3Yonsei University Research Institute of Science for Aging, Yonsei
University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Korea. 4Department
of Family Practice, National Health Insurance Corporation Ilsan Hospital, 100
ilsan-ro ilsan-donggu, Goyang 410-719, Korea.
Received: 10 June 2013 Accepted: 19 March 2014
Published: 1 April 2014
References
1. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin
EM, Breslow JL: Severe hypercholesterolemia and atherosclerosis in
apolipoprotein E-deficient mice created by homologous recombination
in ES cells. Cell 1992, 71:343–353.
2. Jang Y, Paik JK, Hyun YJ, Chae JS, Kim JY, Choi JR, Lee SH, Shin DJ, Ordovas
JM, Lee JH: The apolipoprotein A5–1131 T > C promoter polymorphism
in Koreans: association with plasma APOA5 and serum triglyceride
concentrations, LDL particle size and coronary artery disease.
Clin Chim Acta 2009, 402:83–87.
3. Talmud PJ, Martin S, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA,
Pasternack A, Humphries SE, Syvänne M: APOA5 gene variants, lipoprotein
particle distribution, and progression of coronary heart disease: results
from the LOCAT study. J Lipid Res 2004, 45:750–756.
4. Nabika T, Nasreen S, Kobayashi S, Masuda J: The genetic effect of the
apoprotein AV gene on the serum triglyceride level in Japanese.
Atherosclerosis 2002, 165:201–204.
5. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk
Factors Collaboration, Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di
Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ,
Saleheen D, Lawlor D, Reilly MP, Hingorani AD, Talmud PJ, Danesh J:
Triglyceride-mediated pathways and coronary disease: collaborative
analysis of 101 studies. Lancet 2010, 375:1634–1639.
6. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC,
Krauss RM, Rubin EM: An apolipoprotein influencing triglycerides in
humans and mice revealed by comparative sequencing. Science 2001,
294:169–173.
7. Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, Rubin EM, Pennacchio LA,
Humphries SE: Relative contribution of variation within the APOC3/A4/A5
gene cluster in determining plasma triglycerides. Hum Mol Genet 2002,
11:3039–3046.
8. Sánchez-Moreno C, Ordovás JM, Smith CE, Baraza JC, Lee YC, Garaulet M:
APOA5 gene variation interacts with dietary fat intake to modulate
obesity and circulating triglycerides in a Mediterranean population.
J Nutr 2011, 141:380–385.
9. Kim JY, Kim OY, Koh SJ, Jang Y, Yun SS, Ordovas JM, Lee JH: Comparison of
low-fat meal and high-fat meal on postprandial lipemic response in
non-obese men according to the -1131 T > C polymorphism of the
apolipoprotein A5 (APOA5) gene (randomized cross-over design).
J Am Coll Nutr 2006, 25:340–347.
10. Corella D, Lai CQ, Demissie S, Cupples LA, Manning AK, Tucker KL, Ordovas
JM: APOA5 gene variation modulates the effects of dietary fat intake on
body mass index and obesity risk in the Framingham Heart Study. J Mol
Med (Berl) 2007, 85:119–128.
11. Mattei J, Demissie S, Tucker KL, Ordovas JM: Apolipoprotein A5
polymorphisms interact with total dietary fat intake in association with
markers of metabolic syndrome in Puerto Rican older adults. J Nutr 2009,
139:2301–2308.
12. Lai CQ, Corella D, Demissie S, Cupples LA, Adiconis X, Zhu Y, Parnell LD,
Tucker KL, Ordovas JM: Dietary intake of n-6 fatty acids modulates effect
of apolipoprotein A5 gene on plasma fasting triglycerides, remnant
lipoprotein concentrations, and lipoprotein particle size: the
Framingham Heart Study. Circulation 2062–2070, 2006:113.
13. Lin J, Fang DZ, Du J, Shigdar S, Xiao LY, Zhou XD, Duan W: Elevated levels
of triglyceride and triglyceride-rich lipoprotein triglyceride induced by a
high-carbohydrate diet is associated with polymorphisms of APOA5-
1131 T > C and APOC3-482C > T in Chinese healthy young adults.
Ann Nutr Metab 2011, 58:150–157.
14. Charriere S, Bernard S, Aqallal M, Merlin M, Billon S, Perrot L, Le Coquil E,
Sassolas A, Moulin P, Marcais C: Association of APOA5–1131 T > C and
S19W gene polymorphisms with both mild hypertriglyceridemia and
hyperchylomicronemia in type 2 diabetic patients. Clin Chim Acta 2008,
394:99–103.
Kang et al. Trials 2014, 15:100 Page 9 of 9
http://www.trialsjournal.com/content/15/1/10015. Zhang Z, Lanza E, Kris-Etherton PM, Colburn NH, Bagshaw D, Rovine MJ,
Ulbrecht JS, Bobe G, Chapkin RS, Hartman TJ: A high legume low glycemic
index diet improves serum lipid profiles in men. Lipids 2010, 45:765–775.
16. Shim JS, Oh KW, Suh I, Kim MY, Shon CY, Lee EJ, Nam CM: A study on
validity of a 299 semiquantitative food frequency questionnaire of
Korean adults. Korean J Community Nutr 2002, 7:484–494.
17. Christian JL, Greger JL: Nutrition for living. 4th edition. Redwood City, CA:
Benjamin/Cummings; 1994:111.
18. The American Dietetic Association: Handbook of clinical dietetics. 2nd
edition. New Haven, CT: Yale University Press; 1992:5–39.
19. Lai CQ, Tai ES, Tan CE, Cutter J, Chew SK, Zhu YP, Adiconis X, Ordovas JM:
The APOA5 locus is a strong determinant of plasma triglyceride
concentrations across ethnic groups in Singapore. J Lipid Res 2003,
44:2365–2373.
20. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC: Two
independent apolipoprotein A5 haplotypes influence human plasma
triglyceride levels. Hum Mol Genet 2002, 11:3031–3038.
21. Chandak GR, Ward KJ, Yajnik CS, Pandit AN, Bavdekar A, Joglekar CV, Fall CH,
Mohankrishna P, Wilkin TJ, Metcalf BS, Weedon MN, Frayling TM, Hattersley
AT: Triglyceride associated polymorphisms of the APOA5 gene have very
different allele frequencies in Pune, India compared to Europeans.
BMC Med Genet 2006, 7:76.
22. Lai CQ, Parnell LD, Ordovas JM: The APOA1/C3/A4/A5 gene cluster, lipid
metabolism and cardiovascular disease risk. Curr Opin Lipidol 2005,
16:153–166.
23. Dallongeville J, Cottel D, Wagner A, Ducimetière P, Ruidavets JB, Arveiler D,
Bingham A, Ferrières J, Amouyel P, Meirhaeghe A: The APOA5 Trp19 allele
is associated with metabolic syndrome via its association with plasma
triglycerides. BMC Med Genet 2008, 9:1–9.
24. Hyun YJ, Jang Y, Chae JS, Kim JY, Paik JK, Kim SY, Yang JY, Ordovas JM, Ko
YG, Lee JH: Association of apolipoprotein A5 concentration with serum
insulin and triglyceride levels and coronary artery disease in Korean
men. Atherosclerosis 2009, 205:568–573.
25. Anderson JW, Johnstone BM, Cook-Newell ME: Meta-analysis of the effects
of soy protein intake on serum lipids. N Engl J Med 1995, 333:276–282.
26. Jang Y, Chae JS, Kim OY, Park HJ, Kim JY, Paik JK, Lee S-H, Lee JH: ApoA5-
1131 T > C genotype effects on apolipoprotein A5 and triglyceride levels
in response to dietary intervention and regular exercise (DIRE) in
hypertriglyceridemic subjects. Atherosclerosis 2010, 211:512–519.
27. Suchanek P, Lorenzova A, Poledne R, Hubacek JA: Changes of plasma
lipids during weight reduction in females depends on APOA5 variants.
Ann Nutr Metab 2008, 53:104–108.
28. Katcher HI, Legro RS, Kunselman AR, Gillies PJ, Demers LM, Bagshaw DM,
Kris-Etherton PM: The effects of a whole grain-enriched hypocaloric diet
on cardiovascular disease risk factors in men and women with metabolic
syndrome. Am J Clin Nutr 2008, 87:79–90.
29. Zhan S, Ho SC: Meta-analysis of the effects of soy protein containing
isoflavones on the lipid profile. Am J Clin Nutr 2005, 81:397–408.
30. Temelkova-Kurktschiev T, Stefanov T: Lifestyle and genetics in obesity and
type 2 diabetes. Exp Clin Endocrinol Diabetes 2012, 120:1–6.
31. Dallinga-Thie GM, van Tol A, Hattori H, van Vark-van der Zee LC, Jansen H,
Sijbrands EJ, DALI study group: Plasma apolipoprotein A5 and
triglycerides in type 2 diabetes. Diabetologia 2006, 49:1505–1511.
32. Ishihara M, Kujiraoka T, Iwasaki T, Nagano M, Takano M, Ishii J, Tsuji M, Ide H,
Miller IP, Miller NE, Hattori H: A sandwich enzyme-linked immunosorbent
assay for human plasma apolipoprotein A-V concentration. J Lipid Res
2015–2022, 2005:46.
33. van der Vliet HN, Sammels MG, Leegwater AC, Levels JH, Reitsma PH,
Boers W, Chamuleau RA: Apolipoprotein A-V: a novel apolipoprotein
associated with an early phase of liver regeneration. J Biol Chem 2001,
276:44512–44520.
34. Henneman P, Schaap FG, Havekes LM, Rensen PC, Frants RR, van Tol A,
Hattori H, Smelt AH, van Dijk KW: Plasma apoAV levels are markedly
elevated in severe hypertriglyceridemia and positively correlated with
the APOA5 S19W polymorphism. Atherosclerosis 2007, 193:129–134.
35. Schaap FG, Nierman MC, Berbée JF, Hattori H, Talmud PJ, Vaessen SF,
Rensen PC, Chamuleau RA, Kuivenhoven JA, Groen AK: Evidence for a
complex relationship between apoA-V and apoC-III in patients with
severe hypertriglyceridemia. J Lipid Res 2006, 47:2333–2339.36. Alborn WE, Prince MJ, Konrad RJ: Relationship of apolipoprotein A5 and
apolipoprotein C3 levels to serum triglycerides in patients with type 2
diabetes. Clin Chim Acta 2007, 378:154–158.
37. Hahne P, Krempler F, Schaap FG, Soyal SM, Höffinger H, Miller K, Oberkofler
H, Strobl W, Patsch W: Determinants of plasma apolipoprotein A-V and
APOA5 gene transcripts in humans. J Intern Med 2008, 264:452–462.
38. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC:
Reproducibility and validity of an expanded self-administered
semiquantitative food frequency questionnaire among male health
professionals. Am J Epidemiol 1992, 135:1114–1126.
doi:10.1186/1745-6215-15-100
Cite this article as: Kang et al.: Consumption of whole grains and
legumes modulates the genetic effect of the APOA5 -1131C variant on
changes in triglyceride and apolipoprotein A-V concentrations in
patients with impaired fasting glucose or newly diagnosed type 2
diabetes. Trials 2014 15:100.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
